RESUMEN
To assess the relevance of genetically determined host factors for the prognosis of meningococcal disease, Fc gamma receptor IIA (FcgammaRIIA), the tumor necrosis factor alpha (TNF-alpha) gene promoter region, and plasminogen-activator-inhibitor-1 (PAI-1) gene polymorphisms were studied in 145 patients with meningococcal disease and in 290 healthy controls matched by sex. Distribution of FcgammaRIIA, TNF-alpha, and PAI-1 alleles was not significantly different between patients and controls. Patients with the FcgammaRIIA-R/R 131 allotype scored > or =1 point in the Barcelona prognostic system more frequently than patients with other allotypes (odds ratio, 18.6; 95% confidence interval, 7.1-49.0, P<0.0001), and they had a higher risk of sequelae (odds ratio, 3.5; 95% confidence interval, 1.1-11.7; P=0.03). Fc gamma receptor IIA polymorphism was associated with markers of disease severity, but TNF-alpha and PAI-1 polymorphisms were not.
Asunto(s)
Antígenos CD/genética , Infecciones Meningocócicas/epidemiología , Infecciones Meningocócicas/genética , Inhibidor 1 de Activador Plasminogénico/genética , Polimorfismo Genético , Receptores de IgG/genética , Factor de Necrosis Tumoral alfa/genética , Adolescente , Adulto , Antígenos CD/metabolismo , Estudios de Casos y Controles , Niño , Preescolar , Intervalos de Confianza , Femenino , Marcadores Genéticos , Predisposición Genética a la Enfermedad , Humanos , Incidencia , Masculino , Infecciones Meningocócicas/diagnóstico , Oportunidad Relativa , Inhibidor 1 de Activador Plasminogénico/metabolismo , Probabilidad , Pronóstico , Regiones Promotoras Genéticas , Receptores de IgG/metabolismo , Sensibilidad y Especificidad , Índice de Severidad de la Enfermedad , España/epidemiología , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
CONTEXT: Studies on meningococcal disease in large urban communities have rarely been performed and are usually based on passive epidemiologic surveillance. Active surveillance may provide new insights. OBJECTIVES: To determine epidemiologic, clinical, and bacteriological characteristics and predictors of dismal prognosis (death and sequelae) in meningococcal disease. DESIGN: Prospective, population-based study. SETTING: All the acute care hospitals (n = 24) in Barcelona, Spain. PATIENT: The 643 patients whose conditions were diagnosed from 1987 through 1992 were detected by 2 active surveillance methods. OUTCOME MEASURES: Incidence and notification to Public Health Service. Clinical and bacteriological features were determined. Dismal prognosis predictors were determined by logistic regression. RESULTS: Average annual incidence was 6.41 per 100,000 inhabitants, with no clear trend of change (P = .08). Sensitivity of the Public Health Service surveillance system was 69.1%. Children younger than 10 years from the inner city were at higher risk than those from the highest income district (relative risk, 3.00; 95% confidence interval [CI], 1.84-5.06). Increasing annual incidence of serogroup C (0.82-1.29/100,000; P = .008) and decreasing incidence of serogroup B (5.11-2.82/100,000; P = .004) was noted. Average annual mortality was 0.40 per 100,000 inhabitants, while the annual average potential years of life lost was 18 per 100,000 inhabitants. Overall case-fatality rate was 6.4%. Independent predictors of death were hemorrhagic diathesis (odds ratio [OR], 63; 95% CI, 21-194), focal neurologic signs (OR, 10; 95% CI, 3-30), and age 60 years or older (OR, 6; 95% CI, 2-17), whereas preadmission antibiotic therapy was associated with favorable outcome (OR, 0.07; 95% CI, 0.02-0.3). Four percent of survivors presented with sequelae. Independent predictors of sequelae were hemorrhagic diathesis (OR, 21; 95% CI, 3-131), focal neurologic signs (OR, 16; 95% CI, 5-53), age 60 years or older (OR, 7; 95% CI, 2-26), and age between 15 and 59 years (OR, 5; 95% CI, 2-14), whereas preadmission antibiotic therapy had a protective effect (OR, 0.2; 95% CI, 0.04-0.5). CONCLUSIONS: Active epidemiologic surveillance significantly improved detection of cases and allowed us to observe that meningococcal disease still causes much morbidity and mortality, especially among children living in the inner city. Hemorrhagic diathesis, focal neurologic signs, and age were independent predictors of dismal prognosis, whereas preadmission antibiotic therapy had a protective effect.
Asunto(s)
Infecciones Meningocócicas/epidemiología , Adolescente , Adulto , Factores de Edad , Anciano , Niño , Notificación de Enfermedades , Femenino , Humanos , Incidencia , Modelos Logísticos , Masculino , Meningitis Meningocócica/epidemiología , Infecciones Meningocócicas/complicaciones , Infecciones Meningocócicas/diagnóstico , Infecciones Meningocócicas/mortalidad , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Análisis Multivariante , Neisseria meningitidis/efectos de los fármacos , Neisseria meningitidis/inmunología , Vigilancia de la Población , Pronóstico , Estudios Prospectivos , España/epidemiología , Salud Urbana/estadística & datos numéricosRESUMEN
Group B streptococcus (GBS) is the leading etiologic agent of bacterial meningitis and sepsis during the neonatal period, but it is an infrequent cause of meningitis in adults. We report 12 episodes of group B streptococcal meningitis in adults and review 52 cases reported in the literature. A total of 24 men and 40 women were included in the study; the mean age (+/- SD) was 49.2 +/- 20.5 years (range, 17-89 years). All the patients had cerebrospinal fluid cultures positive for GBS. Eighty-six percent of the patients had comorbid conditions, 50% had a distant focus of infection, and blood cultures yielded GBS for 78.7%. The overall case-fatality rate was 34.4% (22 patients). Factors associated with a poor outcome were advanced mean age (+/- SD) (61.5 +/- 17.4 years vs. 42.8 +/- 19.2 years; P = .0003) and the presence of complications on admission (P = .0001). Seven percent of survivors had neurological sequelae. Group B streptococcal meningitis in adults has become increasingly frequent in recent years; it tends to occur in patients with severe underlying conditions and is associated with a high case-fatality rate. Factors associated with a poor prognosis are advanced age and the occurrence of neurological and extraneurological complications.
Asunto(s)
Meningitis Bacterianas , Infecciones Estreptocócicas , Streptococcus agalactiae , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Meningitis Bacterianas/tratamiento farmacológico , Meningitis Bacterianas/microbiología , Meningitis Bacterianas/fisiopatología , Infecciones Estreptocócicas/tratamiento farmacológico , Infecciones Estreptocócicas/microbiología , Infecciones Estreptocócicas/fisiopatología , Streptococcus agalactiae/aislamiento & purificaciónRESUMEN
More than 200 years ago, Edward Jenner performed an experiment that laid the foundation for the eradication of smallpox and transformed humankind's fight against disease. Smallpox afflicted humankind as no other disease had don; its persistence and diffusion were without parallel. The disease brought down at least three empires. Generations watched helplessly as their children succumbed to the disease or were disfigured or blinded by it. Attempts were made to contain smallpox by isolating its sufferers and, later, by using variolation with varying degrees of success. However, the definitive solution was not found until Jenner's work was done at the end of the 18th century. Milkmaids who had developed cowpox from contact with cow udders informed Jenner that they were protected from the human form of the disease; he listened to their folk wisdom and raised it to the status of scientific fact. Jenner did not discover vaccination, but he was the first to demonstrate that this technique offered a reliable defense against smallpox. It was also a reliable defense against other illnesses, such as poliomyelitis, measles, and neonatal tetanus, although this was not known in Jenner's lifetime.
Asunto(s)
Brotes de Enfermedades/historia , Viruela/historia , Salud Global , Historia del Siglo XV , Historia del Siglo XVI , Historia del Siglo XVII , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XX , Historia Antigua , Historia Medieval , Humanos , Viruela/epidemiología , Viruela/prevención & control , Vacuna contra Viruela/historia , Vacunación/historia , Vacunación/métodosRESUMEN
CONTEXT: Meningococcal disease is associated with significant morbidity and mortality. Development of a prognostic model based on clinical findings may be useful for identification and management of patients with meningococcal infection. OBJECTIVES: To construct and validate a bedside model and scoring system for prognosis in meningococcal disease. DESIGN: Prospective, population-based study. SETTING: Twenty-four hospitals in the metropolitan area of Barcelona, Spain. PATIENTS: A total of 907 patients with microbiologically proven meningococcal disease. Patients diagnosed with meningococcal disease from 1987 through 1990 were used to develop the prognostic model, and those diagnosed in 1991 and 1992 were used to validate it. OUTCOME MEASURES: Clinical independent prognostic factors for mortality in meningococcal disease. The association between outcome and independent prognostic factors was determined by logistic regression analysis. A scoring system was constructed and tested using receiver operating characteristic curves. RESULTS: Among 624 patients in the derivation set, 287 (46%) were male, the mean age was 12.4 years, and 34 patients (5.4%) died. Among 283 patients in the validation set, 124 (43.8%) were male, the mean age was 12.7 years, and 17 patients (6.0%) died. In multivariate analysis, independent predictors of death were hemorrhagic diathesis (odds ratio [OR], 101; 95% confidence interval [CI], 30-333), focal neurologic signs (OR, 25; 95% CI, 7-83), and age 60 years or older (OR, 10; 95% CI, 3-34), whereas receipt of adequate antibiotic therapy prior to admission was associated with reduced likelihood of death (OR, 0.09; 95% CI, 0.02-0.4). Hemorrhagic diathesis was scored with 2 points, presence of focal neurologic signs with 1 point, age of 60 years or older with 1 point, and preadmission antibiotic therapy was scored as -1. The clinical scores of -1, 0, 1, 2, and 3 or more points were associated with a probability of death of 0%, 2.3%, 27.3%, 73.3%, and 100%, respectively. CONCLUSIONS: Hemorrhagic diathesis, focal neurologic signs, and age of 60 years or older were independent predictors of death in meningococcal disease, whereas receipt of adequate antibiotic therapy was associated with a more favorable prognosis. The scoring system presented is simple, is based on findings readily available at the bedside, and may be useful to help guide aggressive therapy.
Asunto(s)
Algoritmos , Mortalidad Hospitalaria , Infecciones Meningocócicas/mortalidad , Evaluación de Resultado en la Atención de Salud , Adolescente , Adulto , Anciano , Antibacterianos/uso terapéutico , Enfermedades del Sistema Nervioso Central/etiología , Niño , Preescolar , Femenino , Trastornos Hemorrágicos/etiología , Hospitales Urbanos , Humanos , Lactante , Modelos Logísticos , Masculino , Infecciones Meningocócicas/tratamiento farmacológico , Infecciones Meningocócicas/fisiopatología , Persona de Mediana Edad , Modelos Estadísticos , Análisis Multivariante , Pronóstico , Estudios Prospectivos , Curva ROC , Índice de Severidad de la Enfermedad , España/epidemiologíaAsunto(s)
Bacteriemia/tratamiento farmacológico , Meningitis Meningocócica/etiología , Penicilinas/uso terapéutico , Cefotaxima/uso terapéutico , Cefalosporinas/uso terapéutico , Niño , Femenino , Humanos , Meningitis Meningocócica/líquido cefalorraquídeo , Resistencia a las Penicilinas , Penicilinas/líquido cefalorraquídeoAsunto(s)
Antibacterianos/uso terapéutico , Infecciones Meningocócicas/tratamiento farmacológico , Neisseria meningitidis , Faringitis/tratamiento farmacológico , Adulto , Humanos , Meningitis Meningocócica/complicaciones , Meningitis Meningocócica/tratamiento farmacológico , Infecciones Meningocócicas/complicaciones , Faringitis/etiología , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Infecciones del Sistema Respiratorio/etiologíaRESUMEN
Neisseria meningitidis is an uncommon cause of acute bacterial conjunctivitis. Twenty-one cases of primary meningococcal conjunctivitis (PMC) are reported herein and 63 cases published in the literature since 1899 are reviewed. In the 84 cases of PMC available for analysis, the male-to-female ratio was 1.76:1; nine of the patients were neonates, 55 were children, and 20 were adults. Conjunctivitis was unilateral in 66.3% of the patients. Gram stain of conjunctival exudate disclosed gram-negative diplococci in all cases in which it was done. Culture of the conjunctival exudate yielded N. meningitidis in all cases, and 44% of the isolated meningococci belonged to serogroup B. Ocular complications, which occurred in 15.5% of the patients, most frequently were corneal ulcers. Systemic meningococcal disease developed in 17.8% of the patients; the overall mortality was 13.3% for patients with PMC complicated by systemic disease. Development of systemic disease was significantly more frequent in patients receiving only topical therapy than in those treated with systemic therapy (31.71% vs. 2.38%; P = .001). Gram-negative diplococci observed in conjunctival exudate are an indication for systemic antibiotic therapy because of the risk of systemic complications associated with the use of topical therapy alone. When properly treated, patients with PMC have a favorable prognosis.
Asunto(s)
Conjuntivitis Bacteriana , Infecciones Meningocócicas , Preescolar , Humanos , Masculino , Estudios RetrospectivosRESUMEN
To evaluate the epidemiological features of human hydatidosis during the first two decades of life, and to assess whether it exists autochthonously in Catalonia, we analysed the patients younger than 20 years who had been diagnosed and/or treated between 1977 and 1985 in 46 hospitals (representing 95% of the hospital beds in Catalonia where surgical therapy for hydatid disease is available). Ninety-five cases were detected in 87 patients. The mean yearly incidence rate was 0.53/100,000. In 81 patients hydatidosis was diagnosed for the first time in their lives, in 11 for the second time, and in three for the third time. Among the first there was a predominance of exclusively pulmonary cysts (41.9%) over those with exclusively hepatic localization (32%) and with simultaneous hepatic and pulmonary localization (13%). Surgical operations were undertaken in 112 instances, with a mortality rate of 2.2%. It was estimated, by the actuarial method, that the likelihood of a second diagnosis of hydatid disease after the surgical removal of all the cysts found at the time of the first diagnosis was 4.2% two years after the last operation, 9.5% after four years, and 24.6% after 7 years. The incidence rate in the immigrant population was 3.03 times higher than the recorded one for Catalonia. Sixteen patients born in Catalonia reported not to have ever traveled out of it; this information was confirmed by the separate parents report. This would confirm the occurrence of autochthonous hydatid disease.